| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 781.57 | 698.14 | 690.63 | 488.32 | 336.55 |
| Total Expenses | 717.53 | 645.55 | 619.70 | 431.43 | 292.72 |
| Profit Before Tax | 50.16 | 52.77 | 71.03 | 57.07 | 44.21 |
| Profit After Tax | 34.83 | 35.65 | 49.97 | 44.63 | 31.33 |
| Operating Profit After Depreciation | 112.54 | 94.65 | 99.87 | 75.97 | 57.60 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 403.85 | 495.62 | 347.45 | 285.13 | 126.71 |
| Total Non Current Assets | 747.48 | 677.74 | 397.97 | 306.97 | 251.80 |
| Total Current Assets | 999.83 | 783.66 | 655.83 | 492.46 | 240.16 |
| Total Assets | 1,747.31 | 1,461.40 | 1,053.80 | 799.43 | 491.96 |
| Total Shareholder's Fund | 789.39 | 760.29 | 482.52 | 439.24 | 183.01 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 195.98 | -29.15 | -30.35 | 1.41 | 83.57 |
| Net Cash Used In Investing Activities | -316.59 | -215.58 | -94.46 | -145.83 | -134.57 |
| Net Cash Used In Financing Activities | 113.07 | 236.53 | 100.29 | 188.43 | 50.73 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 783.41 | 705.14 | 690.81 | 488.59 | 337.04 |
| Total Expenses | 703.49 | 641.50 | 619.70 | 431.43 | 292.72 |
| Profit Before Tax | 66.36 | 63.64 | 71.11 | 57.16 | 44.32 |
| Profit After Tax | 48.41 | 44.06 | 50.05 | 44.72 | 31.44 |
| Operating Profit After Depreciation | 131.30 | 104.47 | 100.05 | 76.24 | 58.09 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 228 | 344.98 | 347.45 | 285.13 | 126.71 |
| Total Non Current Assets | 555.06 | 582.61 | 397.67 | 306.45 | 251.50 |
| Total Current Assets | 1,066.43 | 795.55 | 656.23 | 493.06 | 240.57 |
| Total Assets | 1,621.49 | 1,378.16 | 1,053.90 | 799.51 | 492.07 |
| Total Shareholder's Fund | 808.85 | 765.42 | 482.61 | 439.32 | 183.12 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 198.76 | -134.21 | -30.35 | 1.20 | 83.29 |
| Net Cash Used In Investing Activities | -188.44 | -128.67 | -94.46 | -145.62 | -134.29 |
| Net Cash Used In Financing Activities | -12.14 | 226.19 | 100.29 | 188.43 | 50.73 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 246.56 | 220.02 | 208.66 | 186.73 | 202.82 |
| Total Expenses | 202.65 | 188.12 | 178.70 | 155.22 | 166.44 |
| Profit Before Tax | 15.85 | 5.76 | 5.15 | 14.29 | 3.68 |
| Profit After Tax | 11.39 | 3.69 | 3.37 | 10.26 | 2.41 |
| Operating Profit after Depreciation | 44.92 | 34.10 | 31.94 | 32.74 | 37.02 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 248.63 | 215.60 | 206.68 | 184.58 | 203.75 |
| Total Expenses | 203.25 | 179.34 | 171.73 | 149.90 | 162.58 |
| Profit Before Tax | 19.92 | 11.80 | 12.33 | 19.08 | 7.75 |
| Profit After Tax | 14.66 | 8.77 | 9.31 | 14.23 | 5.19 |
| Operating Profit after Depreciation | 49.25 | 40.52 | 39.32 | 37.99 | 43.82 |
₹1.0/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Pidilite Industries Ltd | ₹1,498.80 | ₹1,52,544.17 |
| SRF Ltd | ₹2,658.95 | ₹78,817.88 |
| Linde India Ltd | ₹6,709.95 | ₹57,222.45 |
| Gujarat Fluorochemicals Ltd | ₹3,680.65 | ₹40,431.94 |
| Navin Fluorine International Ltd | ₹7,186.40 | ₹36,863.93 |
| Fund Name | AUM |
|---|---|
| SBI Comma Fund | 2.51% |
| Sundaram Small Cap Fund | 1.25% |
| AXIS Innovation Fund | 1.17% |
| AXIS Small Cap Fund | 0.81% |
| Mirae Asset Healthcare Fund | 0.62% |
Neogen Chemicals jumped 3.3% to Rs 1,720.46 after the company reported resilient operational performance in Q4 FY26 despite elevated input costs, Dahej transition-related expenses and geopolitical supply chain disruptions.
18 May 2026, 12:33 pm
Of Rs 1 per share
18 May 2026, 10:47 am
On 16 May 2026
13 May 2026, 10:24 am
On 29 March 2026
09 Mar 2026, 12:58 pm
Neogen Chemicals jumped 5.39% to Rs 1401.75 after the company's board approved the allotment of 10 lakh equity shares with a face value of Rs 10 each aggregating to Rs 161 crore, to promorter entity Cadamba Solutions on a preferential basis.
09 Mar 2026, 12:25 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.